Premium
Basophils and plasmacytoid dendritic cells are potential sources for error in flow cytometric monitoring of patients receiving anti‐CD22 therapies. AKA not all anti‐CD22 antibodies are created equal
Author(s) -
AconLaws Malcolm,
Bayerl Michael G.,
Ehman Christopher,
Malysz Jozef,
Boyer Cinda
Publication year - 2011
Publication title -
american journal of hematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.456
H-Index - 105
eISSN - 1096-8652
pISSN - 0361-8609
DOI - 10.1002/ajh.22130
Subject(s) - cd22 , calicheamicin , medicine , b cell , immunology , antibody